Acute hypoxemic respiratory failure may require invasive mechanical ventilation. However, invasive mechanical ventilation is associated with a variety of complications. Non-invasive ventilation has been presented as an alternative treatment but controversy remains. The investigators hypothesize that high-flow nasal cannula system is effective enough to prevent intubation in acute hypoxemic respiratory failure and not inferior to non-invasive ventilation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
74
Noninvasive ventilation: The inspiratory(IPAP) and expiratory positive airways pressure (EPAP), and the levels of FiO2 is set achieve SpO2 \>92% or PaO2 \>65 mmHg.
High flow nasal cannula system: FiO2 and flow rate of oxygen is set to achieve SpO2 \>92% or PaO2 \>65 mmHg.
Asan Medical Center, University of Ulsan College of Medicine
Seoul, South Korea
RECRUITINGSuccess rate of treatment in two groups
Successful treatment is to avoid intubation and achieve PaO2 \>75 mmHg without respiratory distress for 24 hours while spontaneously breathing oxygen provided by a Venturi device at FiO2 0.50.
Time frame: up to 28 days
compliance of treatment
Withdrawl of non-invasive ventilation or high-flow nasal cannula system without intubation because of intolerance
Time frame: up to 28 days
adverse event
Time frame: up to 28 days
hospital length of stay
Time frame: up to 90 days
Hospital mortality
Time frame: up to 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.